Cancer Genetics Reports Fourth Quarter and Full Year 2019 Financial Results and Provides Strategic Business Updates

    NEXT STORY
    Ayala Pharmaceuticals to Present at Upcoming Investor Conferences
    PREV STORY
    Mayo Clinic joins Biomerica’s InFoods® Irritable Bowel Syndrome (“IBS”) Diagnostic-Guided Therapy clinical trial
    Subscribe to PM360
    Follow Us

    Experts on Call

    Get in touch with PM360 Experts On Call

    Ads

    You May Also Like

    Progenics Announces Preliminary Voting Results of Annual Meeting of Shareholders

    author_avatar
    NASDAQ Market News

    Celyad Receives the First US Patent Covering a Method of Producing Allogeneic TCR-Deficient CAR T-Cells

    MONT-SAINT-GUIBERT, Belgium, March 02, 2016 (GLOBE NEWSWIRE) -- Celyad (Euronext Brussels:CYAD) (Paris:CYAD) (NASDAQ:CYAD), a ...

    author_avatar
    NASDAQ Market News

    ICU Medical, Inc. to Present at Raymond James 38th Annual Institutional Investors Conference

    SAN CLEMENTE, Calif., Feb. 27, 2017 (GLOBE NEWSWIRE) -- ICU Medical, Inc. (Nasdaq:ICUI), a ...

    author_avatar
    NASDAQ Market News